Salmaan Qureshi

12 papers receiving 386 citations

Peers

Salmaan Qureshi
Comparison fields: 5 of 46
  • Ophthalmology 361
  • Radiology, Nuclear Medicine and Imaging 230
  • Molecular Biology 38
  • Endocrinology, Diabetes and Metabolism 29
  • Neurology 24
Replace Xuenan Zhuang with:
Xuenan Zhuang China
Sarene Koh United States
Patricia D. Smith United States
Diana Anna Dmuchowska Poland
Joseph Coney United States
Anna Zaleska-Żmijewska Poland
R. Hiller United States
Gabriela Burian United States
STANLEY CHANG United States
Godfrey Quin Australia
Salmaan Qureshi relative to Xuenan Zhuang China Xuenan Zhuang's profile →
Citations per field
00.5×2.6×
Xuenan Zhuang · 1×
Citations per year

Countries citing papers authored by Salmaan Qureshi

Since Specialization
Citations

This map shows the geographic impact of Salmaan Qureshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salmaan Qureshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salmaan Qureshi more than expected).

Fields of papers citing papers by Salmaan Qureshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salmaan Qureshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salmaan Qureshi. The network helps show where Salmaan Qureshi may publish in the future.

Co-authorship network of co-authors of Salmaan Qureshi

This figure shows the co-authorship network connecting the top 25 collaborators of Salmaan Qureshi. A scholar is included among the top collaborators of Salmaan Qureshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salmaan Qureshi. Salmaan Qureshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1
The association between intravitreal ranibizumab therapy and serum cytokine concentrations in patients with diabetic macular edema.
5
2 8
3 31
4 10
5 104
6 13
7 4
8 53
9 104
10 49
11 10
12 8

About Salmaan Qureshi

Salmaan Qureshi is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Nephrology, having authored 12 papers that have together received 399 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (11 papers), Retinal Imaging and Analysis (9 papers) and Retinal and Optic Conditions (7 papers). The work is most often cited by research in Ophthalmology (361 citations), Radiology, Nuclear Medicine and Imaging (230 citations) and Clinical Biochemistry (18 citations). Salmaan Qureshi has collaborated with scholars based in Australia, Singapore and Indonesia. Frequent co-authors include Tien Yin Wong, Peter van Wijngaarden, Robyn H. Guymer, Sanjeewa Wickremasinghe, Eva Fenwick, Ecosse L. Lamoureux, Mohamed Dirani, C Alex Harper, K Michalová and Muhammad Bayu Sasongko. Their work appears in journals such as Ophthalmology, Investigative Ophthalmology & Visual Science and The Medical Journal of Australia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026